Name: Jasper Therapeutics, Inc. (JSPR) Balance Sheet
Creator: FinSpry

Jasper Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Jasper Therapeutics, Inc. (JSPR) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	71.64	86.89	38.25	84.70	19.84
Cash & Short-Term Investments	71.64	86.89	38.25	84.70	19.84
Accounts Receivable	0.00	0.25	0.91	0.55	0.60
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.65	1.19	0.36	0.22	0.04
Total Current Assets	75.81	88.94	41.73	87.83	20.69
Non-Current Assets
Property, Plant & Equipment (Net)	2.85	4.19	5.45	4.83	2.03
Long-Term Investments	0.42	0.00	0.00	0.00	0.00
Other Non-Current Assets	1.24	1.76	1.18	0.99	0.64
Total Non-Current Assets	4.09	5.95	6.63	5.82	0.00
Total Assets	79.90	94.89	48.36	93.65	23.36
Current Liabilities
Accounts Payable	4.03	4.15	1.77	7.52	1.42
Short-Term Debt	1.09	0.00	0.00	0.00	0.00
Accrued Liabilities	6.42	6.94	2.65	1.66	2.05
Other Current Liabilities	0.60	0.32	0.19	5.74	0.55
Total Current Liabilities	15.24	12.37	7.07	13.76	4.01
Non-Current Liabilities
Long-Term Debt	0.72	1.81	2.79	2.38	0.00
Other Non-Current Liabilities	2.26	2.26	2.36	0.64	8.41
Total Non-Current Liabilities	2.99	4.08	5.31	10.37	0.00
Total Liabilities	18.23	16.45	12.37	24.14	14.65
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-240.87	-169.60	-105.14	-67.45	-36.81
Additional Paid-in Capital	302.54	248.04	141.12	136.96	0.00
Shares Outstanding	15.02	11.16	3.80	3.79	0.00
Total Stockholders' Equity	61.67	78.44	35.99	69.52	8.71
Total Liabilities & Equity	79.90	94.89	48.36	93.65	0.00